Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Cancer Society Issues Health Disparities Policy Statement
THURSDAY, April 30 (HealthDay News) -- The American Society of Clinical Oncology (ASCO) is launching an all-out campaign to eliminate cancer health disparities among Hispanics, blacks, Native Americans, and other minorities, who together will account for more than half of the United States' population by the year 2050, according to a policy statement released during a media telebriefing and published online ahead of print April 29 in the Journal of Clinical Oncology.
New Web-based Information Source to Support UK Clinicians
THURSDAY, April 30 (HealthDay News) -- The United Kingdom's National Institute for Health and Clinical Excellence (NICE) has announced the launch of NHS Evidence, a Web-based evidence resource for clinicians, public health professionals of the National Health Service, and others involved in making patient care decisions. The announcement came in the April 30 issue of The Lancet.
Aging, Changing Nation Will Affect New Cancer Diagnoses
THURSDAY, April 30 (HealthDay News) -- Demographic changes in which older adults and minorities account for an increasing share of the population are expected to result in a soaring number of cancer cases in the next 20 years, according to a study released during a media telebriefing and published online ahead of print April 29 in the Journal of Clinical Oncology.
NEJM Commends New Conflict of Interest Proposal
THURSDAY, April 30 (HealthDay News) -- A new proposal to control conflict of interest is notable for its breadth and variety of recommended solutions, according to a Perspective article published online April 29 in the New England Journal of Medicine.
FDA Requires OTC Pain Relievers to Display Warnings
WEDNESDAY, April 29 (HealthDay News) -- Popular over-the-counter (OTC) pain relievers and fever medications containing acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) will be required to display prominent warnings about the risks of liver damage and internal bleeding, under a new rule announced April 28 by the U.S. Food and Drug Administration (FDA).
Pharmacist Involvement May Decrease Medication Errors
TUESDAY, April 28 (HealthDay News) -- Adding a pharmacist to health care teams may significantly decrease patients' risk of adverse drug events and medication errors, according to a report published in the April 27 issue of the Archives of Internal Medicine. A second study indicates that an interdisciplinary medication reconciliation intervention can also reduce unintentional medication discrepancies with potential for harm.
Steep Copayments Increase Risk of Non-Adherence
TUESDAY, April 28 (HealthDay News) -- In patients who are newly diagnosed with a chronic disease, higher out-of-pocket costs for medications are associated with an increased likelihood of non-treatment, according to a study published in the April 27 issue of the Archives of Internal Medicine.
In-Office Visit Offers Benefits Compared to Teledermatology
THURSDAY, April 23 (HealthDay News) -- In general, the use of teledermatology resulted in poorer diagnostic accuracy when evaluating nonpigmented lesions than clinic-based dermatology, according to research published in the April issue of the Journal of the American Academy of Dermatology.
Having Health Insurance May Not Improve Mortality Risk
THURSDAY, April 23 (HealthDay News) -- People without health insurance have about the same mortality rate as people with health insurance, according to an observational study published online April 21 in Health Services Research.
Stretches Without Health Insurance More Common
WEDNESDAY, April 22 (HealthDay News) -- Periods of uninsurance have become more common in recent decades, particularly among those with less education, according to research published in the April 23 issue of the New England Journal of Medicine.
Melanoma Screening Strategies Examined
WEDNESDAY, April 22 (HealthDay News) -- In middle-aged and older men, new strategies are needed to foster the early detection and treatment of melanoma, according to two studies published in the April issue of the Archives of Dermatology.
Continuity of Care Declining for Medicare Beneficiaries
TUESDAY, April 21 (HealthDay News) -- Medicare beneficiaries in the hospital in 2006 were much less likely to be seen there by a familiar physician than those in the hospital a decade earlier, according to a study reported in the April 22/29 issue of the Journal of the American Medical Association.
Psoriasis Associated With Higher Diabetes Risk
TUESDAY, April 21 (HealthDay News) -- Patients with psoriasis are more likely to have diabetes and hypertension compared to their counterparts without the skin condition, according to a study published in the April issue of the Archives of Dermatology.
Phenol Peels Show Benefit in Treating Skin Conditions
MONDAY, April 20 (HealthDay News) -- Phenol peels may be effective in treating actinic keratosis and Bowen disease, according to research published in the April issue of the Journal of the American Academy of Dermatology.
Disturbed Sleep Common in Patients With Psoriasis
FRIDAY, April 17 (HealthDay News) -- In patients with psoriasis, psoriatic arthritis and several other factors are predictors of sleep interference, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Avoterim May Speed Healing, Reduce Scarring
FRIDAY, April 10 (HealthDay News) -- Transforming growth factor β3 (TGFβ3), also known as avotermin, significantly improved the appearance of scars in both the short term and long term in a series of three studies conducted in the United Kingdom, according to research published in the April 11 issue of The Lancet.
Financial Rewards for Healthy Behavior Can Be Effective
FRIDAY, April 10 (HealthDay News) -- Although paying people to engage in healthy behaviors or successfully tackle unhealthy ones can be effective, it may carry unintended consequences, according to an editorial published online April 9 in BMJ.
Golimumab Linked to Psoriatic Arthritis Improvements
FRIDAY, April 10 (HealthDay News) -- Golimumab, a human monoclonal antibody against tumor necrosis factor alpha (TNFα), showed benefits in adults with psoriatic arthritis, according to research published in the April issue of Arthritis & Rheumatism.
Complications Linked to Laser Skin Resurfacing
MONDAY, April 6 (HealthDay News) -- Severe dermatologic complications can develop in patients who undergo fractional CO2 laser resurfacing, according to a study published online March 16 in Lasers in Surgery and Medicine.
Electronic Prescribing Online-Learning Tools Launched
THURSDAY, April 2 (HealthDay News) -- U.S. physicians will be able to better evaluate electronic prescribing systems thanks to a new online learning center on ePrescribing launched April 1 by the American Medical Association.
Changes Needed in New-Drug Evaluation Process
WEDNESDAY, April 1 (HealthDay News) -- The evaluation process for new drugs is overdue for an overhaul, which could provide benefits for the public and the pharmaceutical industry, according to a point-counterpoint commentary published online March 31 in BMJ.
Oxycodone Effective for Herpes Zoster Pain Relief
WEDNESDAY, April 1 (HealthDay News) -- In patients with herpes zoster, controlled-release oxycodone effectively relieves pain and is generally well-tolerated, according to a study published in the April issue of Pain.
New Health Program Leads to Questions in the UK
WEDNESDAY, April 1 (HealthDay News) -- A new British program to improve patient choices and competition in the health care marketplace may lead to excess capacity in some areas and instability in others, according to a commentary published online March 31 in BMJ.
Copyright © 2009 ScoutNews, LLC. All rights reserved.
|Previous: April 2009 Briefing - Cardiology||Next: April 2009 Briefing - Diabetes & Endocrinology|
Reader comments on this article are listed below. Review our comments policy.